Hsiangkuo Yuan is a Neurology physician affiliated with Thomas Jefferson University. OpenAlex indexes 234 publications with 5,790 citations (h-index 34); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Advanced Neuroimaging in Idiopathic Intracranial Hypertension
Sponsor: Thomas Jefferson University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
10 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
76.9%Calcitonin gene-related peptide (CGRP) antagonists20.4%Ajovy Autoinjector50%Aimovig Autoinjector28%Emgality Pen22%Part D<11 patientsSerotonin-1b and Serotonin-1d Receptor Agonist19.9%Rizatriptan74%Sumatriptan Succinate26%Part D<11 patients+ 4 more classes in this area
Sensory organs
9.7%Carbonic Anhydrase Inhibitor4.8%Acetazolamide100%Part D<11 patientsCorticosteroid4.8%Dexamethasone100%Part D≥12 patientsCardiovascular
9.1%Angiotensin receptor blocker (ARB)5.4%Candesartan Cilexetil100%Part D<11 patientsAntiarrhythmic3.8%Mexiletine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2022 per NIH RePORTER. The latest:
- Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches
Thermaquil, Inc.
FY2022$677,548R44NS115460 - Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches
Thermaquil, Inc.
FY2021$998,122R44NS115460
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”